Hims CEO says he'd rather go after rivals' customers than buy their businesses
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)
SAN FRANCISCO — For companies that advertise healthcare services ranging from hair loss treatments to online therapy directly to consumers, it’s been expensive in the last few years to attract new customers.
While there are still predictions that the digital direct-to-consumer industry might consolidate, as some industry experts are expecting this year, Hims & Hers though, one of the few publicly traded digital health companies, likely won’t be among the acquirers, its CEO told Endpoints News on a recent visit to San Francisco, where the company is headquartered.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.